Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases

MLA

Yan Chen, et al. “Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.” Genomics, Proteomics & Bioinformatics, vol. 16, no. 1, Feb. 2018, pp. 50–62. EBSCOhost, https://doi.org/10.1016/j.gpb.2017.03.006.

APA

Yan Chen, Guangping Li, & Ming-Lin Liu. (2018). Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases. Genomics, Proteomics & Bioinformatics, 16(1), 50–62. https://doi.org/10.1016/j.gpb.2017.03.006

Chicago

Yan Chen, Guangping Li, and Ming-Lin Liu. 2018. “Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.” Genomics, Proteomics & Bioinformatics 16 (1): 50–62. doi:10.1016/j.gpb.2017.03.006.